Lazard Asset Management
AMAG

Lazard Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Lazard Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-121,851
Closed -$8.41M – 1185
2015
Q2 		$8.41M Sell
121,851
-36,329
-23% -$2.29M 0.02% 428
2015
Q1 		$8.65M Buy
158,180
+154,440
+4,129% +$7.36M 0.02% 417
2014
Q4 		$159K Buy
3,740
+1,715
+85% +$62K ﹤0.01% 934
2014
Q3 		$64K Buy
+2,025
New +$43.2K ﹤0.01% 908

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management's AMAG Position: Q3 2015 in Review

Lazard Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q3 2015, closing a stake of 121,851 shares — an estimated $8.41M sold.

Lazard Asset Management first reported a position in AMAG in Q3 2014 and held it in 4 quarters. The position peaked at $8.65M in Q1 2015. 210 funds tracked by Wall St. Rank hold AMAG as of Q3 2015.

  • Lazard Asset Management reported no remaining AMAG Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Lazard Asset Management sold 121,851 AMAG Pharmaceuticals shares in Q3 2015, an estimated $8.41M.
  • Lazard Asset Management first reported a position in AMAG Pharmaceuticals in Q3 2014 and held it in 4 quarters.
  • Lazard Asset Management's AMAG Pharmaceuticals position peaked at $8.65M in Q1 2015.
  • 210 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2015.

Based on Lazard Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.